Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

June 17, 2024

https://www.globenewswire.com/news-release/2024/06/17/2899584/0/en/Certara-Launches-Next-Generation-CoAuthor-Generative-AI-Regulatory-Writing-Software.html

RADNOR, Pa., June 17, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq:CERT), a global leader in model-informed drug development, today unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers. It combines generative AI, document templates, Microsoft Word integration, and structured content authoring tools. CoAuthor accelerates the creation of regulatory documents while maintaining a “human in the loop” approach to the use of generative AI.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.